
Modern approaches to the treatment of fibromyalgia
Author(s) -
Tatiana I. Nasonova,
A. Kh. Mukhametzyanova,
G. R. Tabeyeva,
P. A. Chernousov
Publication year - 2021
Publication title -
nevrologiâ, nejropsihiatriâ, psihosomatika
Language(s) - English
Resource type - Journals
eISSN - 2310-1342
pISSN - 2074-2711
DOI - 10.14412/2074-2711-2021-5-83-89
Subject(s) - duloxetine , milnacipran , fibromyalgia , pregabalin , gabapentin , amitriptyline , medicine , biofeedback , mindfulness , doxepin , quality of life (healthcare) , tramadol , physical therapy , pharmacology , anesthesia , antidepressant , psychiatry , alternative medicine , analgesic , clinical psychology , anxiety , nursing , pathology
Fibromyalgia (FM) occurs in 5–12% of patients but is relatively rarely diagnosed, so most patients do not receive adequate treatment. The review analyses pharmacological and non-pharmacological methods of FM treatment. Data suggests that antidepressants (duloxetine, milnacipran, amitriptyline) and antiepileptics (pregabalin, gabapentin) are most effective. Among non-pharmacological methods, the effectiveness of cognitive-behavioral and mindfulness therapy, kinesiotherapy, and biofeedback has been shown. In the management of patients with FM, a combination of non-pharmacological methods and medications can reduce pain and improve the quality of life.